FDA Is 9 Months Late In Publishing Legally Mandated Hemp Guidance, And Congressional Researchers Are Calling The Agency Out
After the bill was signed, FDA was given 90 days to publish it’s lists
The Congressional Research Service (CRS) is continuing to point out the that Food and Drug Administration (FDA) still hasn’t fulfilled a legal mandate to publish a list of known cannabinoids and guidance on hemp product containers as federal laws for the crop and its derivatives are set to change in a way that stakeholders argue will upend the existing market.
Hemp industry operatives have said that the agency’s failure to follow through on what lawmakers directed will make it harder to comply with the law.
Hemp derivatives with less than 0.3 percent delta-9 THC on a dry-weight basis were federally legalized under the 2018 Farm Bill that President Donald Trump signed during his first term in office. But late last year, the president signed new legislation containing provisions that redefined hemp to make it so only products with 0.4 milligrams of total THC per container would remain legal after November 12.
To Read The Rest Of This Article On Marijuana Moment, Click Here
